journal article·2025-12

ROS‐Activatable Cyclodextrin Nanoparticles Remodel Adenosine‐A2AR Pathway for Augmented Photo‐Immunotherapy

Lulu Wang, Miao Yu, Jie Li, Weiyuan Huang, Siqin He, Hao Wang, Fan Tong, Yufan Wang, Xue Xia, Haoxing Wu, Huile Gao, Yang Zhou

Advanced Functional Materials· Volume 35· Issue 52
Publisher page

Abstract

Abstract Massive ATP secretion during photodynamic therapy (PDT) can rapidly degrade into immunosuppressive adenosine (ADO), thus offsetting or even exacerbating anti‐tumor immunity. Delivering ADO‐modulating agents can relieve this immunosuppression, but the dose‐dependent adverse effects and non‐selective inhibition in normal tissues limit their clinical use. In this study, a supramolecular nanoparticle (CTV) based on noncovalent host‐guest recognition between chlorin e6‐modified β‐cyclodextrin and amantadine‐terminated ADO A2A receptor (A2AR) antagonist vipadenant via a ROS‐activatable linker is constructed. Under photo‐irradiation, the CTV ignites the immunogenic cell death (ICD) of tumor cells, while in situ photo‐activation and release of vipadenant effectively blocks ADO‐A2AR interaction. The combination altogether sustains cytotoxic T cell functions and downregulates regulatory T cell activities, resulting in efficient primary tumor and metastasis inhibition. Collectively, such a simple but activatable nanoparticle is presented as a paradigm in synergistic photo‐immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adenosine and Purinergic Signaling · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Tropical Biological Resources of Ministry of Education School of Pharmaceutical Sciences Hainan University Haikou Hainan 570228 P. R. China

Department of Breast Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital & Institute Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu Sichuan 610041 P. R. China

Department of Radiology and Huaxi MR Research Center West China Hospital Sichuan University Chengdu Sichuan 610064 P. R. China

Department of Radiology Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University) Haikou Hainan 570311 P. R. China

Key Laboratory of Drug‐Targeting and Drug Delivery System West China School of Pharmacy Sichuan University Chengdu Sichuan 610064 P. R. China

Funding

National Natural Science Foundation of China

References (31)

Show source-provided references
1. 10.1016/j.jconrel.2022.04.04110.1016/j.jconrel.2022.04.041 ↗
2. 10.1038/s41467-020-19970-910.1038/s41467-020-19970-9 ↗
3. 10.1038/nrc338010.1038/nrc3380 ↗
4. 10.1038/nri.2017.910.1038/nri.2017.9 ↗
5. 10.1038/s41573-024-00920-910.1038/s41573-024-00920-9 ↗
6. 10.1016/j.cclet.2024.11077110.1016/j.cclet.2024.110771 ↗
7. Ma G.‐L. · Mil. Med. Res. · 2023 · 10 · 20
8. 10.1038/s41467-021-24902-210.1038/s41467-021-24902-2 ↗
9. 10.1002/advs.20210418210.1002/advs.202104182 ↗
10. 10.1038/s41467-023-42734-010.1038/s41467-023-42734-0 ↗
11. 10.3389/fimmu.2022.83723010.3389/fimmu.2022.837230 ↗
12. 10.1016/j.apsb.2022.11.00110.1016/j.apsb.2022.11.001 ↗
13. 10.1002/advs.20210479310.1002/advs.202104793 ↗
14. 10.1016/j.cclet.2024.11077510.1016/j.cclet.2024.110775 ↗
15. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
16. 10.1016/j.apsb.2023.10.00610.1016/j.apsb.2023.10.006 ↗
17. 10.1038/s41565-024-01757-410.1038/s41565-024-01757-4 ↗
18. 10.1126/sciadv.adp907110.1126/sciadv.adp9071 ↗
19. 10.1002/EXP.2021011110.1002/EXP.20210111 ↗
20. 10.1016/j.apsb.2024.10.01510.1016/j.apsb.2024.10.015 ↗
21. 10.1016/j.cclet.2024.11070410.1016/j.cclet.2024.110704 ↗
22. 10.1016/j.apsb.2022.07.00610.1016/j.apsb.2022.07.006 ↗
23. 10.1038/s41467-024-54854-210.1038/s41467-024-54854-2 ↗
24. 10.34133/research.027710.34133/research.0277 ↗
25. 10.1016/j.jconrel.2022.09.02910.1016/j.jconrel.2022.09.029 ↗
26. 10.1038/s41590-022-01379-910.1038/s41590-022-01379-9 ↗
27. 10.1186/s40364-023-00500-w10.1186/s40364-023-00500-w ↗
28. 10.1111/imr.1252810.1111/imr.12528 ↗
29. 10.1002/smll.20230059410.1002/smll.202300594 ↗
30. 10.1002/adfm.20210464510.1002/adfm.202104645 ↗
31. 10.1016/j.cej.2022.14083010.1016/j.cej.2022.140830 ↗